Role of daratumumab in the frontline management of multiple myeloma: a narrative review
S Yadav, S Gundeti, A Bhave, U Deb… - Expert Review of …, 2023 - Taylor & Francis
Introduction The prevalence of multiple myeloma (MM) has gradually increased over the last
few decades in India due to growing population, better disease awareness, and improved …
few decades in India due to growing population, better disease awareness, and improved …
Daratumumab in Indian patients with relapsed and refractory multiple myeloma: a prospective, multicenter, phase IV study
L Kumar, S Melinkeri, P Ganesan, J Kumar… - Future …, 2024 - Taylor & Francis
Aim: To assess the safety and effectiveness of daratumumab monotherapy in Indian patients
with relapsed/refractory multiple myeloma. Methods: In this prospective, multicenter, phase …
with relapsed/refractory multiple myeloma. Methods: In this prospective, multicenter, phase …
[PDF][PDF] Role of daratumumab in the frontline management of multiple myeloma: a narrative
S Yadav, S Gundeti, A Bhave, U Deb, J Dixit, K Mishra - 2023 - researchgate.net
Introduction: The prevalence of multiple myeloma (MM) has gradually increased over the
last few decades in India due to growing population, better disease awareness, and …
last few decades in India due to growing population, better disease awareness, and …